Secretin is a 27-amino-acid gut hormone that tells the pancreas to release bicarbonate-rich fluid. A synthetic copy of human secretin is used as a diagnostic agent for pancreas and gastrinoma testing. This guide covers its structure, mechanism, FDA-labeled uses, key studies and label warnings. Sources were checked on November 17, 2026.
Quick answer: Secretin is a prescription diagnostic peptide sold as ChiRhoStim by ChiRhoClin. Its label covers three uses: testing pancreatic exocrine function, helping diagnose gastrinoma, and helping find the pancreatic duct openings during ERCP. The label has no boxed warning and no contraindications. A randomized trial found it did not help autism.
Vitrapep does not sell secretin; this page is a reference summary of published research and regulatory information.
What is secretin?
Secretin is a peptide hormone released by the small intestine. Bayliss and Starling described it in a 1902 paper on the mechanism of pancreatic secretion (Bayliss & Starling, 1902). The ChiRhoStim label describes “synthetic human secretin.” It says the product “has an amino acid sequence identical to the naturally occurring hormone consisting of 27 amino acids” (ChiRhoStim label, 2017).
That chain of 27 amino acids makes it a peptide. The label gives a molecular weight of 3,039.44. PubChem’s “secretin” record, whose synonyms include pig secretin, lists C130H219N43O42 and 3,056.4 g/mol (PubChem CID 16129665). Our guide to peptide hormones covers the wider family of gut and pituitary signals.
Drugs@FDA lists the original approval of ChiRhoStim (NDA 021256) on April 9, 2004, as a new molecular entity with priority review (Drugs@FDA, ChiRhoStim). Two earlier secretin products are now discontinued. SecreFlo, a synthetic porcine secretin, was approved on April 4, 2002 (Drugs@FDA, SecreFlo). Secretin-Ferring (NDA 018290) is listed without an approval date.
Secretin: key facts
| Fact | Detail |
|---|---|
| Structure type | Linear peptide of 27 amino acids (synthetic, identical to human secretin) |
| Class | Gut peptide hormone; diagnostic agent |
| Molecular formula | C130H219N43O42 (PubChem record that includes pig secretin) |
| Molecular weight | 3,039.44 (ChiRhoStim label, human); 3,056.4 g/mol (PubChem) |
| First FDA approval | April 9, 2004 (ChiRhoStim, human); SecreFlo (porcine) April 4, 2002, discontinued |
| Brand names (US) | ChiRhoStim (current); SecreFlo and Secretin-Ferring (discontinued) |
How does secretin work?
Secretin works on the cells that line the pancreatic ducts. Per the ChiRhoStim label, it binds secretin receptors on those duct cells and opens CFTR channels. The cells then release large volumes of pancreatic fluid rich in bicarbonate. The label also notes a possible nerve pathway through the vagus nerve (ChiRhoStim label, 2017).
That response is the basis of the pancreas test. A damaged pancreas makes less bicarbonate after secretin. The gastrinoma test uses a different effect. In the label’s study, secretin raised gastrin above the cutoff in every patient with a gastrinoma, but not in healthy subjects. Sincalide is another gut peptide used in diagnostic testing.
What is secretin approved for?
The ChiRhoStim label lists three uses. It is indicated for stimulation of:
- pancreatic secretions, including bicarbonate, to aid in the diagnosis of pancreatic exocrine dysfunction;
- gastrin secretion to aid in the diagnosis of gastrinoma; and
- pancreatic secretions to help find the ampulla of Vater and accessory papilla during endoscopic retrograde cholangiopancreatography (ERCP).
FDA’s orphan drug database lists a 1999 orphan designation for synthetic human secretin. It covers diagnosis of gastrinoma associated with Zollinger-Ellison syndrome (FDA orphan drug database).
What did the key trials show?
Pancreatic function. The label reports crossover studies comparing ChiRhoStim with porcine secretins in human patients with chronic pancreatitis. In three crossover studies, all 21 chronic pancreatitis patients had peak bicarbonate below the label’s cutoff for normal function. All 35 healthy subjects were at or above it.
Gastrinoma. In a three-way crossover in 6 patients with tissue-confirmed gastrinoma, gastrin rose above the label’s cutoff with every secretin product tested. In 12 healthy subjects, ChiRhoStim testing was completely negative.
ERCP. A randomized, placebo-controlled crossover study enrolled 24 patients with pancreas divisum. The minor duct was successfully cannulated in 16 of 24 with ChiRhoStim and 2 of 24 with placebo (ChiRhoStim label, 2017).
Autism (not an approved use). In 1998, NICHD said secretin’s effect on autism “cannot be determined at this time” (NICHD, 1998). A double-blind, placebo-controlled human trial then randomized 60 children aged 3 to 14 with autism or related disorders. Autism Behavior Checklist scores fell by 8.9 points with secretin and 17.8 with placebo (P = 0.11). The authors concluded it “is not an effective treatment for autism or pervasive developmental disorder” (Sandler et al., 1999).
What side effects does the label list?
The ChiRhoStim label has no boxed warning, and its contraindications section reads “None.” Its most common reactions, each seen in two or more patients, were nausea, vomiting, flushing and upset stomach. Among 531 patients, nausea occurred in 9, vomiting in 3, flushing in 2 and upset stomach in 2.
The label has two warnings, both about test accuracy. Patients with a vagotomy, inflammatory bowel disease or anticholinergic medicines may under-respond to secretin testing. The label also warns of hyperresponse to secretin stimulation testing (ChiRhoStim label, 2017).
What is secretin’s regulatory status, and how is it used in research?
Secretin is a prescription diagnostic agent in the United States. DailyMed lists one prescription label, ChiRhoStim from ChiRhoClin. It also lists two homeopathic “Secretin Cycle” drop products (DailyMed, 2026). The evidence summarized here is human: diagnostic studies in patients and healthy volunteers, plus one autism trial.
Frequently asked questions about secretin
Is secretin a peptide?
Yes. Secretin is a 27-amino-acid peptide hormone. ChiRhoStim is a synthetic copy with the same sequence as the human hormone.
When was secretin approved?
Drugs@FDA lists the original approval of ChiRhoStim on April 9, 2004.
Is secretin a treatment?
No. All three labeled uses are diagnostic: pancreatic function testing, gastrinoma testing and duct identification during ERCP.
Does secretin help autism?
A randomized, placebo-controlled trial in 60 children found no benefit. Autism is not a labeled use.
Does secretin have a boxed warning?
No. Its warnings concern test accuracy, and the label lists no contraindications.
What to know now
- Structure: 27-amino-acid peptide; synthetic human secretin; molecular weight 3,039.44.
- Approval: ChiRhoStim, April 9, 2004; earlier porcine products discontinued; prescription only.
- Mechanism: binds secretin receptors on pancreatic duct cells, releasing bicarbonate-rich fluid.
- Uses: diagnostic only: pancreatic function, gastrinoma and ERCP duct identification.
- Evidence: 16 of 24 versus 2 of 24 for minor duct cannulation; no benefit in autism.
- Safety: no boxed warning; nausea was the most common reaction.
What we’re watching
Any revision to the ChiRhoStim label on DailyMed, last revised in July 2017. Related guides: sincalide, cosyntropin and teduglutide.